Innovations in heart failure management: The role of cutting-edge biomarkers and multi-omics integration
{{output}}
Heart failure (HF) remains a major cause of morbidity and mortality worldwide and represents a major challenge for diagnosis, prognosis and treatment due to its heterogeneity. Traditional biomarkers such as BNP and NT-proBNP are valuable but insufficient to ca... ...
